Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision in the footer advanced from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T13:29:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A notice about NIH website changes and terminology during a transition appears above the clinical trial record.
    Difference
    0.4%
    Check dated 2026-10-26T15:21:51.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer's revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T20:52:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, indicating a site software update.
    Difference
    0.1%
    Check dated 2026-10-13T03:58:36.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record’s revision history was updated to add revision v3.7.0 and remove v3.6.6, indicating a new posting to the record. This reflects an update to the record metadata rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-21T22:48:22.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The record history now indicates a new software revision (v3.6.6) replacing the prior revision (v3.6.5), reflecting a behind-the-scenes release update rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-08-31T16:43:33.000Z thumbnail image

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.